Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years
Clinical trial NCT03344029 · COMPLETED
Trial details
- NCT number
- NCT03344029
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-03
- Primary completion
- 2018-05-22
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.